Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirements compliance to help ensure the security of the materials.

April 2019 Surety Medicine Teleconference:

BLOODBORNE PATHOGEN EXPOSURES:
^{PRE- AND POST-EXPOSURE PROPHYLAXIS}

Wednesday, 20 April 2019 will bring the next Surety Medicine Teleconference,
at 1 pm (1300 hrs) Eastern Time. The topic for April is "Bloodborne Pathogen Exposures: Pre- and Post-Exposure Prophylaxis.” The presenter will be a
Senior Occupational Health Physician from the Army Public Health Center’s
Surety Medicine Program.

To request additional information, email the Army Public Health Center Surety Medicine Program at: usarmy.apg.medcom-aphc.mbx.surety-medicine@mail.mil.

SCHEDULE OF UPCOMING SURETY MEDICINE TELECONFERENCES

(subject to change)

17 APR 2019	Bloodborne Pathogen Exposures: Pre- and Post-Expsoure Prophylaxis
15 MAY 2019	Substance Use Disorder Clinical Care (SUDCC) Intake Evaluations for PRP Candidates: Suggested Approach
19 JUN 2019	Changing Most Probable Event Requirements in the Chemical Storage and Demilitarization Environment
17 JUL 2019	Diagnosis, Evaluation and Treatment of Laboratory-Acquired Botulinum Toxin Exposures
21 AUG 2019	Certifying Official, Behavioral Health Specialist, and CMA Interactions: PRP Case Studies
18 SEP 2019	Urinary Metabolites, Protein Adducts and Bio-markers of Nerve and Vesicant Exposures

--ALERT--

Auto-Injector Shelf Life Extension:

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

Previously extended DuoDote(R) Nerve Agent Autoinjector Kit Lot 9AE306 expired 31 January 2019. Lots 9AE307, 9AE356 and 9AE545 will reach their extended expiration date 31 March 2019.

In addition, three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018, and additional lots expired in September 2018. Check any auto-injector medication stores you have. Select the link below for additional information.

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R) combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to 2022. Complete FDA information related to the auto-injector shelf life extension program can be found at this FDA Drug Safety Page .

Information on this page also includes the latest updates (03/23/2018) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors, with dates listed.

Surety Medicine